Skip to main content
. Author manuscript; available in PMC: 2017 Jan 13.
Published in final edited form as: J Pharm Sci. 2016 Jan 13;105(1):147–159. doi: 10.1016/j.xphs.2015.11.027

Figure 3.

Figure 3

Deposition fraction (DF) predictions (percentage of aerosolized drug mass) in the mouthpiece (MP), mouth-throat (MT) and upper tracheobronchial (TB) regions for the non-constricted and constricted airways with metered dose inhaler (MDI) delivery (a and b) and with dry powder inhaler (DPI) delivery (c and d).